london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

Intravitreal bevacizumab in the management of purtscher’s retinopathy

Poster Details

First Author: K.H.Madan INDIA

Co Author(s):    S. Mittal                  0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

To present a case of Purtscher’s Retinopathy treated with intravitreal Injection of Bevacizumab.

Setting:

Case Report.

Methods:

A thirty five year old male was examined on 25/10/2013. He complained of sudden decrease of vision in both eyes. He gave history of a road side accident 48 hours ago in which he suffered from multiple fractures of clavicle. His best corrected visual acuity on presentation was 6/60 in right eye and counting fingers one metre in left eye. He was diagnosed to have Purtscher’s Retinopathy in both eyes secondary to injury. Optical Coherence Tomography (OCT) showed the presence of thickening of inner retinal layers accompanied by subfoveal serous detachment and cystoid macular edema. Fundus Fluorescein Angiography (FFA) confirmed the presence of Purtscher’s Retinopathy. 3 injections of intravitreal Bevacizumab were given at monthly intervals in right eye on 28/10/2013, 25/11/2013 & 4/1/2014. Similarly 3 injections of intravitreal Bevacizumab were given at monthly intervals in left eye on 4/11/2013, 2/12/2013 & 11/01/2014.

Results:

After 3 months of follow up, his best corrected visual activity improved from 6/60 to 6/6 in right eye and counting fingers only to 6/9 in left eye. The fundus pictures showed decrease in the number of cotton wool spots. Central foveal thickness improved from 396 micron to 243 micron in right eye and from 451 micron to 255 micron in left eye. There was complete resolution of sub-retinal fluid at last follow up.

Conclusions:

Bevacizumab may be useful in treatment of Purtscher’s Retinopathy.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy